Amundi Gilead Sciences, Inc. Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Amundi holds 13,616,387 shares of GILD stock, worth $1.28 Billion. This represents 0.43% of its overall portfolio holdings.

Number of Shares

13,616,387

Previous 11,240,529 21.14%

Holding current value

$1.28 Billion

Previous $771 Million 47.99%

% of portfolio

0.43%

Previous 0.3%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $158 Million - $200 Million	2,375,858 Added 21.14%	13,616,387 $1.14 Billion
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $110 Million - $127 Million	1,739,913 Added 18.31%	11,240,529 $771 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $73 Million - $89 Million	-1,019,938 Reduced 9.69%	9,500,616 $696 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $6.02 Million - $6.82 Million	-82,104 Reduced 0.77%	10,520,554 $852 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $23.4 Million - $25.6 Million	-316,824 Reduced 2.9%	10,602,658 $795 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $22.4 Million - $25.5 Million	294,400 Added 2.77%	10,919,482 $842 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $33.8 Million - $38.5 Million	437,302 Added 4.29%	10,625,082 $882 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1.33 Million - $1.91 Million	-21,368 Reduced 0.21%	10,187,780 $875 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $127 Million - $145 Million	2,126,205 Added 26.3%	10,209,148 $659 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $73.2 Million - $82.4 Million	1,267,513 Added 18.6%	8,082,943 $500 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $99.3 Million - $124 Million	-1,714,000 Reduced 20.1%	6,815,430 $412 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $124 Million - $141 Million	-1,914,086 Reduced 18.33%	8,529,430 $613 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $110 Million - $118 Million	1,617,865 Added 18.33%	10,443,516 $729 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $560 Million - $612 Million	8,825,651 New	8,825,651 $608 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account